Cover Image
市場調查報告書

CountryFocus:巴西的醫療·規定·醫療費給付制度狀況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

出版商 GlobalData 商品編碼 287369
出版日期 內容資訊 英文 247 Pages
訂單完成後即時交付
價格
Back to Top
CountryFocus:巴西的醫療·規定·醫療費給付制度狀況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
出版日期: 2015年07月13日 內容資訊: 英文 247 Pages
簡介

巴西的醫藥品市場一般預測將由2012年的238億美金,到2020年達到588億美金,以年平均(年複合成長率)12%的速度擴大。此外醫療設備的市場規模也將由2012年的79億美金,擴大到2020年的131億美金。老年人口的增加,及醫療保險覆蓋率的上升,是推動該成長的主要原因。

本報告提供巴西的醫療相關市場趨勢,及醫療費給付制度及其他相關法規·制度相關分析,醫藥品產業·醫療設備產業的整體結構與趨勢,醫療費給付制度及其週邊的保險市場趨勢,彙整醫療法規當局結構和各種法規概要,巴西經濟·社會相關宏觀指標(醫療基礎設施等)的資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 醫藥品·醫療設備市場概要

  • 醫藥品市場
    • 市場概況
    • 醫藥品的進出口
    • 供給途徑
    • 市場分類
    • 主要的疾病領域
    • 主要企業
  • 醫療設備市場
    • 市場概況
    • 前幾名5領域概況
    • 診斷市場
    • 主要企業
  • 市場促進·阻礙因素
    • 推動因素
    • 阻礙因素

第4章 市場進入

  • 醫療制度概要
    • 組織結構
  • 醫療費給付·保險費付款者狀況
    • 醫療費給付的過程
    • 藥價制定的次序
    • 保險業者概要
    • 患者負擔在醫療費用支出的比率
    • 處方藥的價格趨勢
    • 藥價政策
  • 法規環境
    • 法規機關概要
    • 新藥的認證過程
    • 學名藥的認證過程
    • 醫療設備新產品的認證過程
    • 醫藥品·醫療設備的製造認證過程
    • 醫藥品的出口·進口的認證
    • 智慧財產權
    • 臨床實驗相關的法規
    • 醫藥品的廣告相關法規
    • 藥局相關的法規
    • 標籤·包裝相關法規

第5章 該國分析

  • 政治環境
  • 經濟環境
  • 經濟指標
  • 人口統計
  • 醫療基礎設施
    • 醫療機構
    • 醫療相關參數
    • 環境問題
    • 醫護人員
  • 醫療費用支出
    • 概要
    • 醫療費用支出的主要因素
    • 官方/民間部門的市場佔有率
    • 醫藥品的研究開發(R&D)活動的支出額
  • 產業團體
  • 展示會

第6章 市場機會與課題

  • 市場機會
  • 課題

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC0081CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Brazil's population in 2013 was approximately 198 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.9% from 2008. The country's increasingly elderly population and the corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was estimated to be worth $14.1 billion in 2008, and is projected to reach approximately $47.9 billion by 2020 at a CAGR of 8.5%. Approximately 60-80% of the Brazilian population has healthcare coverage, which has helped to create one of the most efficient healthcare systems among the BRICS countries, along with the fact that the government has taken new initiatives to promote generic drugs. The medical device market was valued at $6.4 billion in 2008, and is projected to grow at a CAGR of 7.5% to an estimated $14.2 billion in 2020, primarily attributed to -

  • Sedentary lifestyles leading to a high chronic disease burden
  • Easy accessibility to diagnostic technologies
  • Increased accessibility to healthcare professionals in remote areas

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Hypermarcus, Pfizer, Novartis, Roche and EMS Sigma Pharma; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Roche, Essilor, and Philips
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Brazil's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Brazil's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Brazil's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Top Five Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of Top Five Segments
    • 3.2.3. Diagnostic Market
    • 3.2.4. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Overview of the Healthcare System
  • 4.2. Reimbursement and Payer Landscape
    • 4.2.1. Reimbursement Process
    • 4.2.2. Overview of Insurance Providers
    • 4.2.3. Patient Share in Healthcare Spending
    • 4.2.4. Prescription Drug Price Trend
    • 4.2.5. Pricing Policies
  • 4.3. Regulatory Landscape
    • 4.3.1. Overview of Regulatory Agencies
    • 4.3.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.3.3. Market Authorization Procedure for Medical Devices
    • 4.3.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.3.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.3.6. Intellectual Property Rights
    • 4.3.7. Clinical Trial Regulations
    • 4.3.8. Pharmaceutical Advertising Regulations
    • 4.3.9. Pharmacy Regulations
    • 4.3.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. General Government Structural Balance
    • 5.3.9. General Government Net Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy Rate
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.2. Healthcare Facilities
    • 5.5.3. Healthcare Parameters
    • 5.5.4. Environmental Health
    • 5.5.5. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Public and Private Sector Share
    • 5.6.4. Spending in Pharmaceutical Research and Development
  • 5.7. Trade Associations
    • 5.7.1. ABIMO
    • 5.7.2. ABIMED
    • 5.7.3. Interfarma
    • 5.7.4. Abiquifi
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2008-2013
  • Table 2: Pharmaceutical Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Table 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2008-2013
  • Table 4: Pharmaceutical Market, Brazil, Generic Drug Sales ($bn), 2008-2013
  • Table 5: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2013
  • Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, 2014
  • Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015
  • Table 8: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2014
  • Table 9: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2019
  • Table 10: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2014
  • Table 11: Pharmaceutical Market, Roche, Global, Late-Stage Pipeline, 2015
  • Table 12: Medical Device Market, Brazil, Revenue ($bn), 2008-2013
  • Table 13: Medical Device Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Table 14: Medical Device Market, Brazil, Revenue by Segment, 2013
  • Table 15: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Table 16: Medical Device Market, Brazil, Ophthalmic Devices Market, Sales Trends for Major Players, 2012
  • Table 17: Medical Device Market, Brazil, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Table 18: Medical Device Market, Brazil, In Vitro Diagnostics Market, Sales Trends for Major Players, 2012
  • Table 19: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2008-2013
  • Table 20: Medical Device Market, Brazil, Orthopedic Devices Market, Sales Trends for Major Players, 2012
  • Table 21: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2008-2013
  • Table 22: Medical Device Market, Brazil, Diagnostic Imaging Market, Sales Trends for Major Players, 2012
  • Table 23: Medical Device Market, Brazil, Cardiovascular Device Market, Revenue ($bn), 2008-2013
  • Table 24: Medical Device Market, Brazil, Cardiovascular Device Market, Sales Trends for Major Players, 2012
  • Table 25: Medical Device Market, Brazil, Diagnostic Market, Revenue ($bn), 2008-2013
  • Table 26: Medical Device Market, Brazil, Diagnostic Market, Revenue Forecast ($bn), 2014-2020
  • Table 27: Medical Device Market, Brazil, Major Medical Device Companies, Revenue, 2012
  • Table 28: Healthcare System, Brazil, 2014
  • Table 29: Market Access, Brazil, Number of Items Listed in RENAME, 2013-2014
  • Table 30: Healthcare Spending, Brazil, Private Health Plans (million), 2008-2013
  • Table 31: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2008-2013
  • Table 32: Market Access, Brazil, Price Change (%), 2008-2013
  • Table 33: Pricing Policies, Brazil, 2014
  • Table 34: Market Access, Brazil, Compensation Services for Patents ($), 2014
  • Table 35: Market Access, Brazil, Compensation Services for Trademarks ($), 2014
  • Table 36: Healthcare System, Brazil, Documents Required for Dossier Submission of Clinical Trial, 2014
  • Table 37: Economic Indicators, Brazil, GDP per Capita ($), 2008-2013
  • Table 38: Economic Indicators, Brazil, GDP per Capita Forecast ($), 2014-2020
  • Table 39: Economic Indicators, Brazil, GDP Annual Growth (%), 2008-2013
  • Table 40: Economic Indicators, Brazil, GDP Annual Growth Forecast (%), 2014-2020
  • Table 41: Economic Indicators, Brazil, Gross National Income per Capita ($), 2008-2013
  • Table 42: Economic Indicators, Brazil, Average Consumer Price Index, 2008-2013
  • Table 43: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2008-2013
  • Table 44: Economic Indicators, Brazil, Currency Exchange Rate (BRL/$), 2008-2013
  • Table 45: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2008-2013
  • Table 46: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2008-2013
  • Table 47: Economic Indicators, Brazil, Trade balance ($bn), 2008-2013
  • Table 48: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2008-2013
  • Table 49: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2008-2013
  • Table 50: Economic Indicators, Brazil, Government Structural Balance ($bn), 2008-2013
  • Table 51: Economic Indicators, Brazil, General Government Net Debt ($bn), 2008-2013
  • Table 52: Economic Indicators, Brazil, Major Industries (Production Index), 2014
  • Table 53: Demographics, Brazil, Population (million), 2008-2013
  • Table 54: Demographics, Brazil, Population Forecast (million), 2014-2020
  • Table 55: Demographics, Brazil, Population, Urban and Rural Population (%), 2008-2013
  • Table 56: Demographics, Brazil, Population Distribution by Age Group (%), 2008-2013
  • Table 57: Demographics, Brazil, Population Distribution by Age Group Forecast (%), 2014-2020
  • Table 58: Demographics, Brazil, Births (per 1,000 population), 2008-2013
  • Table 59: Demographics, Brazil, Mortality (per 1,000 population), 2008-2013
  • Table 60: Demographics, Brazil, Major Causes of Mortality (per 1,000 population), 2013
  • Table 61: Demographics, Brazil, Children ≥5 Years, Mortality (per 1,000 Live Births), 2008-2013
  • Table 62: Demographics, Brazil, Immunization Rate (%), 2008-2013
  • Table 63: Demographics, Brazil, Major Causes of Male Mortality (per 1,000 population), 2013
  • Table 64: Demographics, Brazil, Major Causes of Female Mortality (per 1,000 population), 2013
  • Table 65: Demographics, Brazil, Gender Ratio (Male/Female), 2008-2013
  • Table 66: Demographics, Brazil, Life Expectancy at Birth (Years), 2008-2013
  • Table 67: Demographics, Brazil, Literacy Rate (%), 2008-2013
  • Table 68: Demographics, Brazil, Employment Rate (%), 2008-2013
  • Table 69: Demographics, Brazil, Major Diseases, DALYs (per 100,000 population), 2004
  • Table 70: Healthcare Infrastructure, Brazil, Type of Hospital (%), 2015
  • Table 71: Healthcare Infrastructure, Hospital Beds by Type of Service, Brazil, 2008-2013
  • Table 72: Healthcare Infrastructure, Hospital beds by Type of Care, Brazil, 2015
  • Table 73: Healthcare Infrastructure, Brazil, Diagnostic Equipment, 2015
  • Table 74: Healthcare Infrastructure, Brazil, Hospital Beds (per 1,000 population), 2008-2013
  • Table 75: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2008-2013
  • Table 76: Healthcare Infrastructure, Brazil, CO2 Emissions (Metric Tons per Capita), 2008-2013
  • Table 77: Healthcare Infrastructure, Brazil, N2O Emissions (Million Metric Tons), 2008-2013
  • Table 78: Healthcare Infrastructure, Brazil, PM10 Emissions (µg/m3), 2008-2013
  • Table 79: Healthcare Infrastructure, Brazil, Nurses (per 1,000 population), 2008-2013
  • Table 80: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2008-2013
  • Table 81: Healthcare Expenditure, Brazil, Share of Major Components (%), 2009
  • Table 82: Healthcare Expenditure, Brazil, Healthcare Expenditure, Public-Private Share (%), 2008-2013
  • Table 83: Healthcare Expenditure, Brazil, Research and Development Expenditure, Share (%), 2008
  • Table 84: Trade Fairs, Brazil, Major Healthcare Trade Fairs, 2015

List of Figures

  • Figure 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2008-2013
  • Figure 2: Pharmaceutical Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Figure 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2008-2013
  • Figure 4: Pharmaceutical Distribution Channels, Brazil, 2011
  • Figure 5: Pharmaceutical Market, Brazil, Generic Drug Sales ($bn), 2008-2013
  • Figure 6: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2013
  • Figure 7: Medical Device Market, Brazil, Revenue ($bn), 2008-2013
  • Figure 8: Medical Device Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Figure 9: Medical Device Market, Brazil, Revenue by Segment ($bn), 2013
  • Figure 10: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Figure 11: Medical Device Market, Brazil, Ophthalmic Devices Market, Sales Trends for Major Players, 2008-2012
  • Figure 12: Medical Device Market, Brazil, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Figure 13: Medical Device Market, Brazil, In Vitro Diagnostics Market, Sales Trends for Major Players, 2008-2012
  • Figure 14: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2008-2013
  • Figure 15: Medical Device Market, Brazil, Orthopedic Devices Market, Sales Trends for Major Players, 2008-2012
  • Figure 16: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2008-2013
  • Figure 17: Medical Device Market, Brazil, Diagnostic Imaging Market, Sales Trends for Major Players, 2008-2012
  • Figure 18: Medical Device Market, Brazil, Cardiovascular Device Market, Revenue ($bn), 2008-2013
  • Figure 19: Medical Device Market, Brazil, Cardiovascular Device Market, Sales Trends for Major Players, 2008-2012
  • Figure 20: Medical Device Market, Brazil, Diagnostic Market, Revenue ($bn), 2008-2013
  • Figure 21: Medical Device Market, Brazil, Diagnostic Market, Revenue Forecast ($bn), 2014-2020
  • Figure 22: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2012
  • Figure 23: Healthcare Market, Brazil, Drivers and Barriers, 2014
  • Figure 24: Healthcare System, Brazil, Reimbursement System, 2014
  • Figure 25: Healthcare System, Brazil, Reimbursement Process, 2014
  • Figure 26: Healthcare Spending, Brazil, Health Insurance Providers, 2014
  • Figure 27: Healthcare System, Brazil, Organization Structure of ANS, 2014
  • Figure 28: Healthcare Spending, Brazil, Private Health Plans (million), 2008-2013
  • Figure 29: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2008-2013
  • Figure 30: Market Access, Brazil, Price Change (%), 2008-2013
  • Figure 31: Healthcare System, Brazil, Flowchart for Classification of Drugs into Categories, 2014
  • Figure 32: Market Access, Brazil, Ministry of Health Structure, 2014
  • Figure 33: Market Access, Brazil, Drug Approval Process, 2014
  • Figure 34: Economic Indicators, Brazil, GDP per Capita ($), 2008-2013
  • Figure 35: Economic Indicators, Brazil, GDP per Capita Forecast ($), 2014-2020
  • Figure 36: Economic Indicators, Brazil, GDP Annual Growth (%), 2008-2013
  • Figure 37: Economic Indicators, Brazil, GDP Annual Growth Forecast (%), 2014-2020
  • Figure 38: Economic Indicators, Brazil, Gross National Income per Capita ($), 2008-2013
  • Figure 39: Economic Indicators, Brazil, Average Consumer Price Index, 2008-2013
  • Figure 40: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2008-2013
  • Figure 41: Economic Indicators, Brazil, Currency Exchange Rate (BRL/$), 2008-2013
  • Figure 42: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2008-2013
  • Figure 43: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2008-2013
  • Figure 44: Economic Indicators, Brazil, Trade Balance ($bn), 2008-2013
  • Figure 45: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2008-2013
  • Figure 46: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2008-2013
  • Figure 47: Economic Indicators, Brazil, Government Structural Balance ($bn), 2008-2013
  • Figure 48: Economic Indicators, Brazil, General Government Net Debt ($bn), 2008-2013
  • Figure 49: Economic Indicators, Brazil, Major Industries (Production Index), 2014
  • Figure 50: Demographics, Brazil, Population (million), 2008-2013
  • Figure 51: Demographics, Brazil, Population Forecast (million), 2014-2020
  • Figure 52: Demographics, Brazil, Population, Urban and Rural Population (%), 2008-2013
  • Figure 53: Demographics, Brazil, Population Distribution by Age Group (%), 2008-2013
  • Figure 54: Demographics, Brazil, Population Distribution by Age Group Forecast (%), 2014-2020
  • Figure 55: Demographics, Brazil, Births (per 1,000 population), 2008-2013
  • Figure 56: Demographics, Brazil, Mortality (per 1,000 population), 2008-2013
  • Figure 57: Demographics, Brazil, Major Causes of Mortality (per 1,000 population), 2013
  • Figure 58: Demographics, Brazil, Children ≥5 Years, Mortality (per 1,000 Live Births), 2008-2013
  • Figure 59: Demographics, Brazil, Immunization Rate (%), 2008-2013
  • Figure 60: Demographics, Brazil, Major Causes of Male Mortality (per 1,000 population), 2013
  • Figure 61: Demographics, Brazil, Major Causes of Female Mortality (per 1,000 population), 2013
  • Figure 62: Demographics, Brazil, Gender Ratio (Male/Female), 2008-2013
  • Figure 63: Demographics, Brazil, Life Expectancy at Birth (Years), 2008-2013
  • Figure 64: Demographics, Brazil, Literacy Rate (%), 2008-2013
  • Figure 65: Demographics, Brazil, Employment Rate (%), 2008-2013
  • Figure 66: Demographics, Brazil, Major Diseases, DALYs (per 100,000 population), 2004
  • Figure 67: Healthcare Infrastructure, Brazil, Type of Hospital (%), 2015
  • Figure 68: Healthcare Infrastructure, Hospital Beds by Type of Service, Brazil, 2008-2013
  • Figure 69: Healthcare Infrastructure, Hospital Beds by Type of Care, Brazil, 2015
  • Figure 70: Healthcare Infrastructure, Brazil, Diagnostic Equipment, 2015
  • Figure 71: Healthcare Infrastructure, Brazil, Total Hospital Beds (per 1,000 population), 2008-2013
  • Figure 72: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2008-2013
  • Figure 73: Healthcare Infrastructure, Brazil, CO2 Emissions (Metric Tons per Capita), 2008-2013
  • Figure 74: Healthcare Infrastructure, Brazil, N2O Emissions (Million Metric Tons), 2008-2013
  • Figure 75: Healthcare Infrastructure, Brazil, PM10 Emissions (µg/m3), 2008-2013
  • Figure 76: Healthcare Infrastructure, Brazil, Nurses (per 1,000 population), 2008-2013
  • Figure 77: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2008-2013
  • Figure 78: Healthcare Expenditure, Brazil, Share of Major Components (%), 2012
  • Figure 79: Healthcare Expenditure, Brazil, Public-Private Share (%), 2008-2013
  • Figure 80: Healthcare Expenditure, Brazil, Research and Development Expenditure, Share (%), 2008
  • Figure 81: Healthcare Market, Brazil, Opportunities and Challenges, 2014
Back to Top